002006: Renin Activity, Plasma | Labcorp (original) (raw)

1. Hurwitz S, Cohen RJ, Williams GH. Diurnal variation of aldosterone and plasma renin activity: timing relation to melatonin and cortisol and consistency after bed rest. J Appl Physiol (1985). 2004 Apr;96(4):1406-1414.14660513

2. Stowasser M, Ahmed AH, Pimenta E, et al. Factors affecting the aldosterone/renin ratio. Horm Metab Res. 2012 Mar;44(3):170-176.22147655

3. Funder JW, Carey RM, Mantero F, et al. The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2016 May;101(5):1889-1916.26934393

4. Laragh JH, Sealey JE. The plasma renin test reveals the contribution of body sodium-volume content (V) and renin-angiotensin (R) vasoconstriction to long-term blood pressure. Am J Hypertens. 2011 Nov;24(11):1164-1180.21938070

5. Galati SJ. Primary aldosteronism: Challenges in diagnosis and management. Endocrinol Metab Clin North Am. 2015 Jun;44(2):355-369.26038205

6. Galati SJ, Hopkins SM, Cheesman KC, Zhuk RA, Levine AC. Primary aldosteronism: emerging trends. Trends Endocrinol Metab. 2013 Sep;24(9):421-430.23796656

7. Weiner ID. Endocrine and hypertensive disorders of potassium regulation: Primary aldosteronism. Semin Nephrol. 2013 May;33(3):265-276.23953804

8. Cicala MV, Mantero F. Primary aldosteronism: What consensus for the diagnosis. Best Pract Res Clin Endocrinol Metab. 2010 Dec;24(6):915-921.21115160

9. Van Der Gugten JG, Holmes DT. Quantitation of Plasma Renin Activity in Plasma Using Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS). Methods Mol Biol. 2016;1378:243-253.26602136

10. Warnock DG. Liddle syndrome: Genetics and mechanisms of Na+ channel defects. Am J Med Sci. 2001 Dec; 322(6):302-307.11780687

11. Stewart PM. 11 beta-Hydroxysteroid dehydrogenase: Implications for clinical medicine. Clin Endocrinol (Oxf). 1996 May;44(5):493-499.8762725

12. Geller DS, Farhi A, Pinkerton N, et al. Activating mineralocorticoid receptor mutation in hypertension exacerbated by pregnancy. Science 2000 Jul 7; 289(5476):119-123.10884226

13. Simpoulos AP, Marshall JR, Delea CS, Bartter FC. Studies on the deficiency of 21-hydroxylation in patients with congenital adrenal hyperplasia. J Clin Endocrinol Metab. 1971 Mar; 32(3):438-443.4322392

14. Shizuta Y, Kawamoto T, Mitsuuchi Y, et al. Inborn errors of aldosterone biosynthesis in humans. Steroids. 1995 Jan;60(1):15-21.7792802

15. Wong L, Hsu TH, Perlroth MG, Hofmann LV, Haynes CM, Katznelson L. Reninoma: Case Report and literature review. J Hypertens. 2008 Feb;26(2):368-373.18192852

16. Gottardo F, Cesari M, Morra A, Gardiman M, Fassina A, Dal Bianco M. A kidney tumor in an adolescent with severe hypertension and hypokalemia: An uncommon case--case report and review of the literature on reninoma. Urol Int. 2010;85(1):121-124.20453480

17. Cho MJ, Sung EY, Park JA, Lee HD. Congestive heart failure as an initial manifestation of reninoma. J Pediatr Endocrilol Metab. 2011;24(11-12):1085-1087.22308872

18. Campbell DJ, Nussberger J, Stowasser M, et al. Activity assays and immunoassays for plasma Renin and prorenin: information provided and precautions necessary for accurate measurement. Clin Chem. 2009 May;55(5):867-877.19264850

19. Ahmed AH, Gordon RD, Taylor PJ, Ward G, Pimenta E, Stowasser M. Effect of contraceptives on aldosterone/renin ratio may vary according to the components of contraceptive, renin assay method, and possibly route of administration. J Clin Endocrinol Metab. 2011 Jun;96(6):1797.21411552

20. Ahmed AH, Gordon RD, Taylor PJ, Ward G, Pimenta E, Stowasser M. Are women more at risk of false-positive primary aldosteronism screening and unnecessary suppression testing than men? J Clin Endocrinol Metab. 2011 Feb;96(2):E340-346.20962019